# FirstCash Holdings, Inc.: financial statements, quarterly

FCFS · Nasdaq · CIK 840489 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fcfs.md) · [Financials](/companies/fcfs/financials.md) · [Filings](/companies/fcfs/filings.md) · [Insiders](/companies/fcfs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fcfs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [335](/filings/0000840489-24-000127.md) | [397 d](/filings/0000840489-26-000032.md) | [367](/filings/0000840489-25-000061.md) | [363](/filings/0000840489-25-000098.md) | [363](/filings/0000840489-25-000120.md) | [414 d](/filings/0000840489-26-000032.md) | [371](/filings/0000840489-26-000049.md) | [385](/filings/0000840489-26-000085.md) | [411](/filings/0000840489-25-000120.md) | [501 d](/filings/0000840489-26-000032.md) | [465](/filings/0000840489-26-000049.md) | [471](/filings/0000840489-26-000085.md) |
| Cost of revenue | $m | [398](/filings/0000840489-24-000127.md) | [434 d](/filings/0000840489-26-000032.md) | [441](/filings/0000840489-25-000061.md) | [436](/filings/0000840489-25-000098.md) | [433](/filings/0000840489-25-000120.md) | [450 d](/filings/0000840489-26-000032.md) | [412](/filings/0000840489-26-000049.md) | [418](/filings/0000840489-26-000085.md) | [462](/filings/0000840489-25-000120.md) | [529 d](/filings/0000840489-26-000032.md) | [509](/filings/0000840489-26-000049.md) | [541](/filings/0000840489-26-000085.md) |
| Gross profit | $m | [389](/filings/0000840489-24-000127.md) | [418 d](/filings/0000840489-26-000032.md) | [396](/filings/0000840489-25-000061.md) | [395](/filings/0000840489-25-000098.md) | [405](/filings/0000840489-25-000120.md) | [434 d](/filings/0000840489-26-000032.md) | [424](/filings/0000840489-26-000049.md) | [413](/filings/0000840489-26-000085.md) | [474](/filings/0000840489-25-000120.md) | [530 d](/filings/0000840489-26-000032.md) | [542](/filings/0000840489-26-000049.md) | [534](/filings/0000840489-26-000085.md) |
| Interest expense | $m | [24.7](/filings/0000840489-23-000112.md) | [26.6 d](/filings/0000840489-24-000042.md) | [25.4](/filings/0000840489-24-000087.md) | [25.2](/filings/0000840489-24-000108.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [20.5](/filings/0000840489-24-000127.md) | [21.9 d](/filings/0000840489-26-000032.md) | [20.5](/filings/0000840489-25-000061.md) | [17.1](/filings/0000840489-25-000098.md) | [20.4](/filings/0000840489-25-000120.md) | [26.0 d](/filings/0000840489-26-000032.md) | [27.6](/filings/0000840489-26-000049.md) | [21.3](/filings/0000840489-26-000085.md) | [29.7](/filings/0000840489-25-000120.md) | [38.6 d](/filings/0000840489-26-000032.md) | [37.4](/filings/0000840489-26-000049.md) | [33.5](/filings/0000840489-26-000085.md) |
| Net income | $m | [57.1](/filings/0000840489-24-000127.md) | [69.6 d](/filings/0000840489-26-000032.md) | [61.4](/filings/0000840489-25-000120.md) | [49.1](/filings/0000840489-25-000120.md) | [64.8](/filings/0000840489-25-000120.md) | [83.5 d](/filings/0000840489-26-000032.md) | [83.6](/filings/0000840489-26-000085.md) | [59.8](/filings/0000840489-26-000085.md) | [82.8](/filings/0000840489-25-000120.md) | [104 d](/filings/0000840489-26-000032.md) | [108](/filings/0000840489-26-000085.md) | [93.5](/filings/0000840489-26-000085.md) |
| Diluted EPS | $ per share | [1.26](/filings/0000840489-24-000127.md) | not reported | [1.35](/filings/0000840489-25-000061.md) | [1.08](/filings/0000840489-25-000098.md) | [1.44](/filings/0000840489-25-000120.md) | not reported | [1.87](/filings/0000840489-26-000049.md) | [1.34](/filings/0000840489-26-000085.md) | [1.86](/filings/0000840489-25-000120.md) | not reported | [2.43](/filings/0000840489-26-000049.md) | [2.12](/filings/0000840489-26-000085.md) |
| Basic EPS | $ per share | [1.27](/filings/0000840489-24-000127.md) | not reported | [1.36](/filings/0000840489-25-000061.md) | [1.09](/filings/0000840489-25-000098.md) | [1.45](/filings/0000840489-25-000120.md) | not reported | [1.87](/filings/0000840489-26-000049.md) | [1.35](/filings/0000840489-26-000085.md) | [1.87](/filings/0000840489-25-000120.md) | not reported | [2.44](/filings/0000840489-26-000049.md) | [2.13](/filings/0000840489-26-000085.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [86.5](/filings/0000840489-24-000127.md) | [127](/filings/0000840489-25-000032.md) | [135](/filings/0000840489-25-000061.md) | [114](/filings/0000840489-25-000098.md) | [106](/filings/0000840489-25-000120.md) | [175](/filings/0000840489-26-000032.md) | [146](/filings/0000840489-26-000049.md) | [101](/filings/0000840489-26-000085.md) | [130](/filings/0000840489-25-000120.md) | [125](/filings/0000840489-26-000085.md) | [131](/filings/0000840489-26-000049.md) | [172](/filings/0000840489-26-000085.md) |
| Current assets | $m | [1,235](/filings/0000840489-24-000127.md) | [1,307](/filings/0000840489-25-000032.md) | [1,257](/filings/0000840489-25-000061.md) | [1,273](/filings/0000840489-25-000098.md) | [1,329](/filings/0000840489-25-000120.md) | [1,404](/filings/0000840489-26-000032.md) | [1,326](/filings/0000840489-26-000049.md) | [1,375](/filings/0000840489-26-000085.md) | [1,792](/filings/0000840489-25-000120.md) | [1,856](/filings/0000840489-26-000085.md) | [1,905](/filings/0000840489-26-000049.md) | [2,019](/filings/0000840489-26-000085.md) |
| Total assets | $m | [4,175](/filings/0000840489-24-000127.md) | [4,290](/filings/0000840489-26-000032.md) | [4,247](/filings/0000840489-25-000061.md) | [4,322](/filings/0000840489-25-000098.md) | [4,393](/filings/0000840489-25-000120.md) | [4,477](/filings/0000840489-26-000032.md) | [4,426](/filings/0000840489-26-000049.md) | [4,514](/filings/0000840489-26-000085.md) | [5,182](/filings/0000840489-25-000120.md) | [5,301](/filings/0000840489-26-000085.md) | [5,361](/filings/0000840489-26-000049.md) | [5,486](/filings/0000840489-26-000085.md) |
| Current liabilities | $m | [317](/filings/0000840489-24-000127.md) | [336](/filings/0000840489-25-000032.md) | [315](/filings/0000840489-25-000061.md) | [316](/filings/0000840489-25-000098.md) | [308](/filings/0000840489-25-000120.md) | [339](/filings/0000840489-26-000032.md) | [302](/filings/0000840489-26-000049.md) | [327](/filings/0000840489-26-000085.md) | [359](/filings/0000840489-25-000120.md) | [408](/filings/0000840489-26-000085.md) | [400](/filings/0000840489-26-000049.md) | [413](/filings/0000840489-26-000085.md) |
| Total liabilities | $m | [2,257](/filings/0000840489-24-000127.md) | [2,293](/filings/0000840489-25-000032.md) | [2,202](/filings/0000840489-25-000061.md) | [2,344](/filings/0000840489-25-000098.md) | [2,394](/filings/0000840489-25-000120.md) | [2,423](/filings/0000840489-26-000032.md) | [2,368](/filings/0000840489-26-000049.md) | [2,374](/filings/0000840489-26-000085.md) | [2,983](/filings/0000840489-25-000120.md) | [3,024](/filings/0000840489-26-000085.md) | [3,063](/filings/0000840489-26-000049.md) | [3,164](/filings/0000840489-26-000085.md) |
| Long-term debt | $m | [1,597](/filings/0000840489-24-000127.md) | [1,606](/filings/0000840489-25-000032.md) | [1,544](/filings/0000840489-25-000061.md) | [1,680](/filings/0000840489-25-000098.md) | [1,731](/filings/0000840489-25-000120.md) | [1,729](/filings/0000840489-26-000032.md) | [1,707](/filings/0000840489-26-000049.md) | [1,685](/filings/0000840489-26-000085.md) | [2,213](/filings/0000840489-25-000120.md) | [2,208](/filings/0000840489-26-000032.md) | [2,254](/filings/0000840489-26-000049.md) | [2,346](/filings/0000840489-26-000085.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,918](/filings/0000840489-24-000127.md) | [1,996](/filings/0000840489-25-000032.md) | [2,045](/filings/0000840489-25-000061.md) | [1,978](/filings/0000840489-25-000098.md) | [1,999](/filings/0000840489-25-000120.md) | [2,054](/filings/0000840489-26-000032.md) | [2,058](/filings/0000840489-26-000049.md) | [2,140](/filings/0000840489-26-000085.md) | [2,200](/filings/0000840489-25-000120.md) | [2,277](/filings/0000840489-26-000085.md) | [2,298](/filings/0000840489-26-000049.md) | [2,322](/filings/0000840489-26-000085.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [111 d](/filings/0000840489-24-000127.md) | [99.1 d](/filings/0000840489-26-000032.md) | [123](/filings/0000840489-25-000061.md) | [106 d](/filings/0000840489-25-000098.md) | [113 d](/filings/0000840489-25-000120.md) | [198 d](/filings/0000840489-26-000032.md) | [127](/filings/0000840489-26-000049.md) | [117 d](/filings/0000840489-26-000085.md) | [136 d](/filings/0000840489-25-000120.md) | [207 d](/filings/0000840489-26-000032.md) | [154](/filings/0000840489-26-000049.md) | [177 d](/filings/0000840489-26-000085.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [15.5 d](/filings/0000840489-24-000127.md) | [15.8 d](/filings/0000840489-26-000032.md) | [15.8](/filings/0000840489-25-000061.md) | [15.9 d](/filings/0000840489-25-000098.md) | [17.0 d](/filings/0000840489-25-000120.md) | [17.0 d](/filings/0000840489-26-000032.md) | [16.9](/filings/0000840489-26-000049.md) | [16.9 d](/filings/0000840489-26-000085.md) | [18.6 d](/filings/0000840489-25-000120.md) | [18.4 d](/filings/0000840489-26-000032.md) | [18.5](/filings/0000840489-26-000049.md) | [18.4 d](/filings/0000840489-26-000085.md) |
| Share repurchases | $m | [13.7 d](/filings/0000840489-24-000127.md) | [(1.1) d](/filings/0000840489-26-000032.md) | [0.0](/filings/0000840489-25-000061.md) | [85.0 d](/filings/0000840489-25-000098.md) | [0.0 d](/filings/0000840489-25-000120.md) | [0.0 d](/filings/0000840489-26-000032.md) | [59.6](/filings/0000840489-26-000049.md) | [0.9 d](/filings/0000840489-26-000085.md) | [30.0 d](/filings/0000840489-25-000120.md) | [25.4 d](/filings/0000840489-26-000032.md) | [50.0](/filings/0000840489-26-000049.md) | [66.9 d](/filings/0000840489-26-000085.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [47.0](/filings/0000840489-23-000112.md) | [46.3](/filings/0000840489-24-000087.md) | [45.7](/filings/0000840489-24-000108.md) | [45.4](/filings/0000840489-24-000127.md) | [45.4](/filings/0000840489-25-000061.md) | [45.3](/filings/0000840489-25-000098.md) | [45.0](/filings/0000840489-25-000120.md) | [44.8](/filings/0000840489-26-000049.md) | [44.6](/filings/0000840489-26-000085.md) | [44.5](/filings/0000840489-25-000120.md) | [44.2](/filings/0000840489-26-000049.md) | [44.0](/filings/0000840489-26-000085.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 43,371,800 at 2026-07-22, from the cover of the [10-Q filed 2026-07-27](/filings/0000840489-26-000085.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.